A role for ITPA variants in the clinical course of pulmonary Langerhans' cell histiocytosis?

European Respiratory Journal

Volumn 36, Issue 3, 2010, Pages 684-686

  Bakker, J A ^a   Bierau, J ^a   Drent, M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INOSINE TRIPHOSPHATASE; MERCAPTOPURINE; PHOSPHATASE; THIOPURINE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; CIGARETTE SMOKING; CORTICOSTEROID THERAPY; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HISTIOCYTOSIS X; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; LANGERHANS CELL; LETTER; LUNG DISEASE; LUNG FIBROSIS; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; SMOKING CESSATION; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

CELL PROLIFERATION; COHORT STUDIES; ERYTHROCYTES; GENETIC VARIATION; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LUNG; LUNG DISEASES; PYROPHOSPHATASES; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME;

EID: 77956566328     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00026610     Document Type: Letter

References (10)

1. Harari S, Caminati A. Pulmonary Langerhans' cell histiocytosis. Eur Respir Mon 2009; 46: 155-175.
2. Weinshilboum R, Wang L. Pharmacogenomics: bench to bedside. Nat Rev Drug Discov 2004; 3: 739-748.
3. Bakker JA, Bierau J, Drent M. Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction? Eur Respir J 2007; 30: 821-822.
4. Coulthard S, Hogarth L. The thiopurines: an update. Invest New Drugs 2005; 23: 523-532.
5. Bierau J, Bakker JA, Lindhout M, et al. Determination of ITPase activity in erythrocyte lysates obtained for determination of TPMT activity. Nucleosides Nucleotides Nucleic Acids 2006; 25: 1129-1132.
6. Sumi S, Marinaki AM, Arenas M, et al. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum Genet 2002; 111: 360-367.
7. Vanderheiden BS. Human erythrocyte "ITPase": an ITP pyrophosphohydrolase. Biochim Biophys Acta 1970; 215: 555-558.
8. Bierau J, Lindhout M, Bakker JA. Pharmacogenetic significance of inosine triphosphatase. Pharmacogenomics 2007; 8: 1221-1228.
9. Lin S, McLennan AG, Ying K, et al. Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the ITPA gene. J Biol Chem 2001; 276: 18695-18701. (Pubitemid 37411183)
10. Arenas M, Duley J, Sumi S, et al. The ITPA c.94C>A and g.IVS2+21A>C sequence variants contribute to missplicing of the ITPA gene. Biochim Biophys Acta 2007; 1772: 96-102. (Pubitemid 44960729)